Nursing home residents living with dementia are at heightened risk of hospitalization. These hospitalizations incur estimated healthcare costs of $2.6...
The clinical outcomes for about 95% of long-term care residents living with dementia could be improved by applying longstanding research to the bedsid...
CMS, in its new guidance for long-term care surveyors now taking effect on April 28, 2025, specifies practices for Gradual Dose Reduction (GDR) for re...
Steven L. Posar, MD, GuideStar CEO and Founder, was recently a guest on a Gerontological Advanced Practice Nurses Association production, the GAPNA Ch...
Nursing homes will soon be subject to new, more stringent surveyor guidance about psychotropic medications for residents, now effective April 28, 2025...
CMS announced major changes in long-term care surveyor guidance that will now take effect on April 28, 2025. Under the new provisions, use of psychotr...
“Approaching dementia care with a neurology-first mindset can bring positive results to residents in long term care,” said Provider in an introduction...
It’s well documented that use of antipsychotics in dementia care can lead to an array of adverse medical outcomes. Recent research suggests that antip...
Long-term care clinicians are continuously challenged to find ways to keep residents happy, healthy, and at home. In this era of managed cared models...
Institutional Special Needs Plans (I-SNPs) are catching on in long-term care. A Special Needs Plan (SNP) in the Medicare Advantage program addresses t...
Only just identified in 2019, LATE is now the focus of intensive dementia research—and surprises are emerging. Based on continuing discoveries, here a...
In longterm care facilities, CMS compliance depends on ensuring diagnostic accuracy and avoiding unnecessary use of antipsychotics and other psychotro...
